Drug Trial Radar · NCT05970575
Insulin-sensitizing NE3107 in Improving Sleep and Fatigue in Subjects With Traumatic Brain Injury
Last checked: Nov 19, 2026Latest source record: Jul 25, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
4
Actual
Start
Dec 21, 2023
Primary completion
Jul 21, 2025
Study completion Jul 21, 2025
Sponsor
- Lead sponsor
- Neurological Associates of West Los AngelesAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- BioVie Inc.
- First posted
- Aug 1, 2023
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 74 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study seeks to measure changes in cognition through verbal and visual test procedures and changes in biomarkers of Traumatic Brain Injury and inflammatory and metabolic parameters.
Conditions
- Traumatic Brain Injury
Interventions
NE3107Drug
Participants will take 20mg twice daily (BID) approximately 12 hours apart. The dose will be stable the duration of the study intervention (6 months)
Primary outcomes
What the sponsor says the trial is designed to measure.
- Safety as Assessed by Quantification of Adverse EventsTime frame: up to 6 months
- Pittsburgh Sleep Quality Index (PSQI)Time frame: Baseline, 3 months, 6 months
- Multidimensional Fatigue Inventory (MFI)Time frame: Baseline, 3 Months, 6 Months
Locations
1 site in 1 country. Site status is shown where the registry gives one.
The Regenesis Project
Santa Monica, California
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.